Related Experiment Video
Updated: Jul 30, 2025

12:43
A Protocol for Comprehensive Assessment of Bulbar Dysfunction in Amyotrophic Lateral Sclerosis ALS
Published on: February 21, 2011
34.9K
Bulbar Onset Amyotrophic Lateral Sclerosis: A Case Report
Kabindra Rai1, Nilshan Rai1, Milan Kumar Chhantel Thapa1
1KIST Medical College and Teaching Hospital, Mahalaxmi, Lalitpur, Nepal.
JNMA; Journal of the Nepal Medical Association
|May 19, 2023
Summary
This case report details a 45-year-old male with bulbar onset amyotrophic lateral sclerosis (ALS). Early diagnosis and interventions like gastrostomy tubes and Edaravone improved his prognosis and survival.
Area of Science:
- Neurology
- Neurodegenerative Disorders
Background:
- Amyotrophic lateral sclerosis (ALS) is a progressive, incurable neurodegenerative disease affecting motor neurons.
- Bulbar onset ALS presents with specific symptoms such as hoarseness and aspiration.
Observation:
- A 45-year-old male presented with hoarseness, tongue fasciculations, and aspiration.
- Over three years, he developed motor aphasia, frequent aspirations, and neck weakness.
- Diagnosis of bulbar onset ALS was confirmed based on neurodegenerative features and normal imaging.
Findings:
- Management included a percutaneous endoscopic gastrostomy tube to prevent aspiration pneumonia.
- Respiratory failure necessitated tracheostomy and mechanical ventilation.
- Two courses of Edaravone were administered during treatment.
Implications:
- This case highlights the importance of early evaluation and diagnosis in ALS.
- Timely management, including nutritional support and respiratory care, is crucial for improving patient outcomes.
- The use of Edaravone in this case provides insights into potential therapeutic strategies for ALS.
Related Concept Videos
Parkinson's Disease: Overview
617
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
617
Parkinson's Disease: Treatment
311
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
311
Amyloid Fibrils
9.6K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.6K
Myasthenia Gravis: Overview and Treatment
1.7K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.7K
Myasthenia Gravis: Diagnostic Tests
1.1K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
1.1K

